Clinical trials recruiting in Steglitz, Germany

Phase breakdown

Conditions recruiting in Steglitz, Germany

Recruiting trials in Steglitz, Germany

• A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
  NCT07169578 · Phase: Phase 3 · Ages: 50 Years to 90 Years · Sex: All (male and female)
• A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)
  NCT06780150 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Dopamine Modulation of Motivation and Motor Function in Major Depression & Inflammation
  NCT05909267 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female)
• Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
  NCT04075084 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Yoga-based Group Intervention (YoGI) for In-patients With Schizophrenia Spectrum Disorders
  NCT04730518 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 90 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Steglitz, Germany?

5 recruiting trials have at least one study site in Steglitz, Germany.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.